Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Rachele Vaia
Observed name:
R Vaia
Institutions:
University of Verona,
Azienda Ospedaliera Universitaria Integrata Verona
Observed institutions:
University of Verona,
Azienda Ospedaliera Universitaria Integrata Verona
ORCID:
0000-0002-2148-6383
Observed ORCID:
0000-0002-2148-6383
OpenAlex ID:
A5087094577
Uncontrolled Asthma: Unmet Needs in the Management of Patients
2021
·
Marco Caminati
, Rachele Vaia
, et al.
·
Journal of Asthma and Allergy
·
63
PDF
Diagnosis and Management of Allergic Rhinitis in Asthmatic Children
2023
·
Laura Tenero
, Rachele Vaia
, et al.
·
Journal of Asthma and Allergy
·
53
PDF
Severe Asthma, Telemedicine, and Self-Administered Therapy: Listening First to the Patient
2022
·
Gabriella Guarnieri
, Marco Caminati
, et al.
·
Journal of Clinical Medicine
·
24
PDF
New horizons for the treatment of severe, eosinophilic asthma: benralizumab, a novel precision biologic
2019
·
Marco Caminati
, Diego Bagnasco
, et al.
·
Biologics
·
19
PDF
Dupilumab Efficacy on Asthma Functional, Inflammatory, and Patient-Reported Outcomes across Different Disease Phenotypes and Severity: A Real-Life Perspective
2024
·
Marco Caminati
, Matteo Maule
, et al.
·
Biomedicines
·
18
PDF
Benralizumab Efficacy in Late Non-Responders to Mepolizumab and Variables Associated with Occurrence of Switching: A Real-Word Perspective
2023
·
Marco Caminati
, Alessandro Marcon
, et al.
·
Journal of Clinical Medicine
·
14
PDF
Extracellular Vesicles in Asthma: Intercellular Cross-Talk in TH2 Inflammation
2025
·
Naila Arif Cheema
, Annalisa Castagna
, et al.
·
Cells
·
11
PDF
Profiling Blood Hypereosinophilia in Patients on Dupilumab Treatment for Respiratory Conditions: A Real-Life Snapshot
2025
·
Marco Caminati
, Matteo Maule
, et al.
·
The Journal of Allergy and Clinical Immunology In Practice
·
11
PDF
Low-dose anti-IL 5 treatment in idiopathic hypereosinophilic syndrome: towards a precision medicine approach for remission maintenance
2023
·
Marco Caminati
, Matteo Maule
, et al.
·
Orphanet Journal of Rare Diseases
·
10
PDF
Hidden Comorbidities in Asthma: A Perspective for a Personalized Approach
2023
·
Matteo Maule
, Bianca Olivieri
, et al.
·
Journal of Clinical Medicine
·
9
PDF
Relevance of Smoking Habit in Severe Asthma Patients: Evidence from the Severe Asthma Network in Italy (SANI) Registry
2022
·
Marco Caminati
, Gabriella Guarnieri
, et al.
·
Journal of Clinical Medicine
·
7
PDF
Successful switching from mepolizumab to dupilumab in a patient with EGPA in remission phase and persistent nasal polyposis
2023
·
Marco Caminati
, Elena Scarpieri
, et al.
·
Rheumatology
·
5
Profiling severe asthma: Any relevance for age? An analysis from Severe Asthma Network Italy (SANI) cohort
2024
·
Marco Caminati
, Alessandro Marcon
, et al.
·
World Allergy Organization Journal
·
3
PDF
Upper and lower airways response to tezepelumab in asthma patients with / without comorbid nasal polyposis: a 6-months reallife perspective
2026
·
M Caminati
, A Mastrototaro
, et al.
·
Rhinology Journal
·
2
PDF
Trends of T2 and Non-T2 Cytokines During Mepolizumab Treatment in Different Asthma Patient Subgroups
2026
·
Marco Zurlo
, Francesca Ambrosani
, et al.
·
Biomedicines
PDF
Serum Ige levels and blood eosinophils as potential Th2 inflammation biomarkers and target to address Chronic Cough: a retrospective analysis
2023
·
Carlo Barbetta
, Anna Del Colle
, et al.
·
European Respiratory Journal
Blood eosinophils in a cohort of Chronic Cough Patients consecutively admitted to a dedicated outpatient clinic: a retrospecitive case note analysis
2023
·
Carlo Barbetta
, Anna Del Colle
, et al.
·
European Respiratory Journal
Schweres Asthma, Telemedizin und selbst verabreichte Therapie: Zuerst auf den Patienten hören
2022
·
Gabriella Guarnieri
, Marco Caminati
, et al.
·
Kompass Pneumologie
PDF
Show more works
View as search
Works count:
18
Citation count:
249
H-index:
9
I10-index:
9
Year
Topic
Type